| Literature DB >> 24727949 |
Zhenling Peng1, Yoshihisa Sakai2, Lukasz Kurgan1, Bernd Sokolowski2, Vladimir Uversky3.
Abstract
The large-conductance Ca2+-activated K+ (BK) channel is broadly expressed in various mammalian cells and tissues such as neurons, skeletal and smooth muscles, exocrine cells, and sensory cells of the inner ear. Previous studies suggest that BK channels are promiscuous binders involved in a multitude of protein-protein interactions. To gain a better understanding of the potential mechanisms underlying BK interactions, we analyzed the abundance, distribution, and potential mechanisms of intrinsic disorder in 27 BK channel variants from mouse cochlea, 104 previously reported BK-associated proteins (BKAPS) from cytoplasmic and membrane/cytoskeletal regions, plus BK β- and γ-subunits. Disorder was evaluated using the MFDp algorithm, which is a consensus-based predictor that provides a strong and competitive predictive quality and PONDR, which can determine long intrinsically disordered regions (IDRs). Disorder-based binding sites or molecular recognition features (MoRFs) were found using MoRFpred and ANCHOR. BKAP functions were categorized based on Gene Ontology (GO) terms. The analyses revealed that the BK variants contain a number of IDRs. Intrinsic disorder is also common in BKAPs, of which ∼ 5% are completely disordered. However, intrinsic disorder is very differently distributed within BK and its partners. Approximately 65% of the disordered segments in BK channels are long (IDRs) (>50 residues), whereas >60% of the disordered segments in BKAPs are short IDRs that range in length from 4 to 30 residues. Both α and γ subunits showed various amounts of disorder as did hub proteins of the BK interactome. Our analyses suggest that intrinsic disorder is important for the function of BK and its BKAPs. Long IDRs in BK are engaged in protein-protein and protein-ligand interactions, contain multiple post-translational modification sites, and are subjected to alternative splicing. The disordered structure of BK and its BKAPs suggests one of the underlying mechanisms of their interaction.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24727949 PMCID: PMC3984161 DOI: 10.1371/journal.pone.0094331
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
A list of functional annotations with corresponding number of disordered segments.
| Function | Number of Disordered Segments | ||
| Membrane/Cytoskeletal Partners | Cytoplasmic Partners | BK Variants | |
| Protein-protein binding | 25 | 20 | 7 |
| Substrate/ligand binding | 5 | 5 | 26 |
| Protein-DNA binding | 8 | 6 | 7 |
| Flexible linkers/spacers | 7 | 4 | 3 |
| Phosphorylation | 2 | 8 | 3 |
| Intra-protein interaction | 3 | 2 | 3 |
| Protein-lipid interaction | 6 | 2 | 0 |
| Metal binding | 4 | 3 | 0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The list shows 27, 36 and 26 disordered segments from membrane/cytoskeletal and cytoplasmic partners, and from BK channel variants, respectively. The functions are sorted in descending order by total number of segments. Functions shown in italics were annotated for less than 5 segments.
Figure 1Overall characterization of intrinsic disorder in BK and BKAPs.
(A) Fraction of predicted fully disordered proteins and average disorder content. (B) Number of predicted disordered segments and long (30 or more consecutive residues) disordered segments per protein. (C) Distribution of the length of putative disordered segments. The bar charts in panels A and B report median values with the corresponding 25th and 75th centiles (shown as error bars). *p<0.01, **for p-value<0.001.
Figure 2Number of predicted MoRF regions per protein for BK channel variants and cytoplasmic and membrane/cytoskeletal BKAPs.
The bars are subdivided into different colors to denote MoRF types. The bar chart shows median values with the corresponding 25th and 75th centiles (shown as error bars). *p<0.01; **for p<0.001.
Figure 3Overall characterization of BK channel variants.
Sequence profiles of BK for (A) all 22 considered variants, (B) 6 DEC type variants, (C) 7 ERL type variants, and (D) 9 VYR type variants. Profile includes sequence conservation (uppermost plot), sites of mutations between different variants (gray), regions inserted/deleted through alternative splicing (black), majority-vote based (a given annotation is considered if it occurs in at least 50% of variants at a given position in the chain) profiles for putative disorder (red), MoRFs (pink), globular domains (green), and four types of ELMs (blue). ELMs include cleavage sites (CLV), ligand binding sites (LIG), sites of posttranslational modification (MOD) and subcellular targeting sites (TRG).
Characterization of rates of mutation and disorder, and average evolutionary conservation for different ELMs found in BK.
| ELM Type | Mutations (%) | Disordered (%) | Average conservation |
| CLV | 25.0 | 41.7 | 0.72 |
| LIG | 28.6 | 23.8 | 0.98 |
| MOD | 26.5 | 26.5 | 0.81 |
| TRG | 37.5 | 25.0 | 0.80 |
| All types | 31.9 | 29.8 | 0.97 |
ELMs are subdivided into cleavage sites (CLV), ligand binding sites (LIG), posttranslational modification sites (MOD), and subcellular targeting sites (TRG).
Figure 4Characterization of putative functions for disordered regions using Gene Ontology (GO).
Fraction of disordered segments for a given function is grouped by three protein sets, including BK and cytoplasmic and membrane/cytoskeletal BKAPs. The eight functions are sorted by decreasing number of disordered segments from the BK channel. The bar chart reports median fraction of disordered regions with a given putative function with the corresponding 25th and 75th centiles (shown as error bars). *p<0.01, **p<0.001.
Figure 5Comparisons of BK intrinsic disorder with BK crystal structures.
(A) Crystal structure of the intracellular C-terminal domain of human BK in a form showing the gating ring constituted as a modified tetramer (PDB ID: 3NAF) [68]. (B) A crystal structure of the non-modified monomer of this domain (PDB ID: 3MT5) [63]. Comparison of disorder profiles determined for: (C) the construct used in the crystallization experiments of residues 341–1056 [63] (numbered in plot as 1–715), (D) isoform-5 of human BK (UniProt ID: Q17921-5), and (E) the DEC variant of mouse BK (UniProt ID: C3VLD3). Disorder propensities were predicted using four members of the PONDR family depicted as different colors.
Figure 6Effect of alternative splicing on the disorder propensity of human BK.
Disorder profiles are shown for: (A) Canonical isoform (Q17921-1), (B) Isoform-2 (Q17921-2), (C) Isoform-3 (Q17921-3), (D) Isoform-4 (Q17921-4), (E) Isoform-5 (Q17921-5), (F) Isoform-6 (Q17921-6), (G) Isoform-7 (Q17921-7). Disorder propensities were predicted using four members of the PONDR family depicted as different colors.
Figure 7Intrinsic disorder profiles for BK accessory proteins.
Disorder profiles are shown for β-subunits (A) KCNMB1 (Q8CAE3), (B) KCNMB2 (Q9CZM9), (C) KCNMB3 (E9Q7U0), and (D) KCNMB4 (Q9JIN6), and γ-subunits (E) LRRC26 (Q91W20), (F) LRRC38 (A2VDH3), (G) LRRC52 (Q5M8M9), and (H) LRRC55 (Q3UY51). Disorder propensities were evaluated using four members of the PONDR family.
Figure 8Intrinsic disorder profiles for hub proteins of the BK interactome.
Disorder profiles are shown for: (A) NMDA receptor (P35436), (B) α-actin (P68134), (C) Aspartate aminotransferase (P05201), (D) α-tubulin (P68368), (E) ATP synthase beta subunit (P56480), (F) protein kinase C epsilon (P16054), (G) γ-actin (P63268), (H) β-actin (P60710), (I) calmodulin (P62204), (J) Protein SET (Q9EQU5), (K) and chromobox homolog 1 (P83917). Disorder propensities were evaluated using four members of the PONDR family.
The extent of disorder-based interaction sites (MoRFs and AIBSs) in hub proteins of the BK interactome.
| Protein (UniProt ID) | Number of AIBSs | AIBS location | Number of MoRFs | MoRF location |
| Glutamate receptor ionotropic, NMDA (P35436) | 20 | 927–932, 942, 966–968, 972–986, 998–1000, 1012–1028, 1044–1065, 1086–1107, 1115–1121, 1130–1147, 1182–1193, 1217–1224, 1234–1247, 1278–1281, 1322–1333, 1336–1337, 1375–1379, 1400–1407, 1423–1429, 1448–1453 | 35 | 9–16, 37–41, 67–72, 199–205, 222–226, 249–260, 281–286, 333–345, 358–367, 409–417, 473–480, 578–583, 602–614, 632–640, 692–705, 729–735, 775–780, 792–798, 816–821, 836–847, 864–874, 896–904, 925–931, 942–961, 970–982, 1008–1021, 1045–1058, 1097–1105, 1130–1154, 1184–1194, 1286–1301, 1321–1331, 1360–1375, 1422–1430, 1447–1464 |
| Actin, α skeletal muscle (P68134) | 1 | 376–377 | 9 | 11–17, 71–76, 90–94, 139–142, 222–226, 243–255, 261–264, 353–360, 372–377 |
| Aspartate aminotransferase, cytoplasmic (P05201) | 1 | 19–20 | 14 | 10–25, 44–56, 116–125, 155–163, 182–194, 210–226, 238–248, 264–270, 287–292, 310–320, 332–339, 355–368, 373–380, 405–413 |
| Tubulin α-4A chain (P68368) | 2 | 20–25, 51–54 | 8 | 19–28, 46–58, 86–90, 132–140, 141–159, 313–342, 401–409, 422–438 |
| ATP synthase subunit β (P56480) | 2 | 37–39, 339–341 | 12 | 27–38, 61–73, 139–150, 176–180, 186–193, 214–222, 250–256, 285–292, 303–310, 356–364, 388–396, 521–529 |
| Protein kinase C epsilon type (P16054) | 5 | 126–130, 298–308, 323–326, 352–371,406–413 | 17 | 7–13, 36–47, 125–133, 212–222, 300–311, 317–326, 328–341, 345–363, 371–383, 401–419, 436–441, 497–500, 524–540, 590–603, 620–633, 666–678, 724–737 |
| Actin, γ-enteric smooth m. (P63268) | 0 | 5 | 10–17, 88–94, 221–225, 242–263, 370–376 | |
| Actin, cytoplasmic 1 (P60710) | 1 | 374–375 | 5 | 5–16, 84–93, 220–224, 241–262, 369–375 |
| Calmodulin (P62204) | 5 | 10–21, 64–73, 90–93, 100–106, 139–146 | 5 | 9–20, 32–38, 67–75, 87–96, 140–149 |
| Protein SET (Q9EQU5) | 5 | 1–14, 20–29, 92–94, 134–141, 199–289 | 8 | 3–13, 38–56, 139–142, 171–178, 197–210, 225–238, 251–266, 280–289 |
| Chromobox protein homolog 1 (P83917) | 4 | 33–45, 56–71, 115–140, 152–169 | 5 | 15–29, 32–46, 62–73, 131–141, 163–171 |
Hub proteins are defined as proteins involved in at least 6 protein-protein interactions.